HOME > Research


Utility of fast non-…
Utility of fast non-local means (FNLM) filter for detection …

Purpose: This study was aimed to evaluate the utility based on imaging quality of the fast non-local means (FNLM) filter in diagnosing lung nodules in pediatric chest computed tomography (CT).

Methods: We retrospectively reviewed the chest CT reconstructed with both filtered back projection (FBP) and iterative reconstruction (IR) in pediatric patients with metastatic lung nodules. After applying FNLM filter with six h values (0.0001, 0.001, 0.01, 0.1, 1, and 10) to the FBP images, eight sets of images including FBP, IR, and FNLM were analyzed. The image quality of the lung nodules was evaluated objectively for coefficient of variation (COV), contrast to noise ratio (CNR), and point spread function (PSF), and subjectively for noise, sharpness, artifacts, and diagnostic acceptability.

Results: The COV was lowest in IR images and decreased according to increasing h values and highest with FBP images (P < 0.001). The CNR was highest with IR images, increased according to increasing h values and lowest with FBP images (P < 0.001). The PSF was lower only in FNLM filter with h value of 0.0001 or 0.001 than in IR images (P < 0.001). In subjective analysis, only images of FNLM filter with h value of 0.0001 or 0.001 rarely showed unacceptable quality and had comparable results with IR images. There were less artifacts in FNLM images with h value of 0.0001 compared with IR images (p < 0.001).

Conclusion: FNLM filter with h values of 0.0001 allows comparable image quality with less artifacts compared


Jina Shim, Myonggeun Yoon*

Department of Bio-Convergence Engineering, Korea University, Seoul, Republic of Korea

Department of Diagnostic Radiology, Severance Hospital, Seoul, Republic of Korea

Mi-Jung Lee* 

Department of Radiology and Research Institute of Radiological Science, Severance Children’s Hospital, Yonsei University, College of Medicine, Seoul, Republic of Korea

Youngjin Lee

Department of Radiological Science, Gachon University, Incheon, Republic of Korea


Physica Medica 81 (2021) 52-89

Inter fractional ent…
Inter fractional entrance dose monitoring as quality assuran…
Introduction: This study describes a simple method of inter‑fractional photon beam monitoring to measure the entrance dose of radiation treatment using Gafchromic EBT3 film. 
Materials and Methods: The film was placed at the center of a 1‑cm thick phantom shaped like a block tray and fixed on the accessory tray of the gantry. The entrance dose was measured following the placement of the film in the accessory tray. The dose distribution calculated with the treatment planning system was compared with the dose distribution on the irradiated EBT3 films. The effectiveness of this methodology, as determined by gamma passing rates, was evaluated for the 22 fields of eight three‑dimensional conformal radiotherapy (3D‑CRT) plans and the 41 fields of nine intensity‑modulated radiotherapy (RT) plans. The plans for three‑dimensional conformal RT included treatments of the rectum, liver, breast, and head and neck, whereas the plans for intensity‑modulated RT included treatments of the liver, brain, and lung. 
Results: The gamma passing rates for 3D‑CRT ranged from 96.4% to 99.5%, with the mean gamma passing rate for 22 fields being 98.0%. The gamma passing rate for intensity‑modulated RT ranged from 96.1% to 98.9%, with the mean gamma passing rate for 41 fields being 97.7%. All gamma indices were over the 95% tolerance level. 
Conclusions: The methodology described in this study, based on Gafchromic EBT3 film, can be utilized for inter‑fractional entrance dose monitoring as quality assurance during RT. Clinical application of this method to patients can verify the accuracy of beam delivery in the treatment room.

Sun Young Moon
Department of Bio‑convergence Engineering, Korea University, Seoul
Proton Therapy Center, National Cancer Center, Goyang, Korea
Yunhui Jo, Jaehyeon Seo, Myonggeun Yoon
Department of Bio‑convergence Engineering, Korea University, Seoul 
Dongho Shin,  
Proton Therapy Center, National Cancer Center, Goyang, Korea

Journal of Cancer Research and Therapeutics - Volume 18 - Issue 4 - July-September 2022: 1152-1158
The combination of t…
The combination of tumor treating fields and hyperthermia ha…

Glioblastoma multiforme (GBM), the most common type of brain tumor, is a very aggressive and treatment-refractory cancer, with a 5-year survival rate of approximately 5%. Hyperthermia (HT) and tumor treating fields (TTF) therapy have been used to treat cancer, either alone or in combination with other treatment methods. Both treatments have been reported to increase the efficacy of other treatment techniques and to improve patient prognosis. The present study evaluated the therapeutic effects of combining HT and TTF on GBM cell lines. Cells were subjected to HT, TTF, HT+TTF, or neither treatment, followed by comparisons of cell proliferation, apoptosis, migration and invasiveness. Clonogenic assays showed that the two treatments had a synergistic effect. The levels of cleaved PARP and cleaved caspase-3 were higher and apoptosis was increased in cells treated with HT+TTF than in cells treated with HT or TTF alone. In addition, HT+TTF showed greater inhibition of GBM cell migration and invasiveness and greater downregulation of STAT3 than either HT or TTF alone. The stronger anticancer effect of HT+TTF suggested that this combination treatment can increase the survival rate of patients with difficult-to-treat cancers such as GBM.


Yunhui Jo, Young In Han

Institute of Global Health Technology (IGHT), Korea University, Seoul, Republic of Korea

Eunjun Lee, Geon Oh, Heehun Sung, Yongha Gi, Hyunwoo Kim, Sangmin Park

Department of Biomedical Engineering, Korea University, Seoul, Republic of Korea

Jaehyeon Seo

Department of Bioconvergence Engineering, Korea University, Seoul, Republic of Korea 

Myonggeun Yoon

Department of Biomedical Engineering, Korea University, Seoul, Republic of Korea

Department of Bioconvergence Engineering, Korea University, Seoul, Republic of Korea


Am J Cancer Res. 2022; 12(3): 1423–1432.

Tumor treating field…
Tumor treating fields (TTF) treatment enhances radiation-ind…
Purpose:Tumor treating fields (TTF) therapy is a noninvasive method that uses alternating electric fields to treat various types of cancer. This study demonstrates the combined effect of TTF and radiotherapy (RT) in vitro on pancreatic cancer, which is known to be difficult to treat. 
Materials  and  methods: In CFPAC-I and HPAF-II pancreatic cancer cell lines, the combined in vitro effect of TTF and RT was evaluated by measuring cell counts, markers of apoptosis, and clonogenic  cell  survival.  The  synergy  effects  were  verified  using  the  Valeriote  and Carpentier equations. 
Results: TTF and RT inhibited cancer cell growth more effectively than did mono therapy with TTF or RT. The combined treatment also enhanced apoptosis more than mono therapy, as shown by as says for cleaved poly (ADP-ribose) polymerase (PARP) and annexin V. In addition, on the survival curve, this treatment method has been shown to work synergistically.
Conclusion:These results suggest that combined treatment with TTF and RT may be a good alter-native treatment for patients with pancreatic cancer

Yunhui Jo

Department of Bio-convergence Engineering, Korea University, Seoul, Korea

Geon Oh, Yongha Gi, Heehun Sung, Myonggeun Yoon

Department of Bio-medical Engineering, Korea University,Seoul, Korea

Eun Bin Joo, Suk Lee

Department of Radiation Oncology, College of Medicine, Korea University, Seoul, Korea


INTERNATIONAL JOURNAL OF RADIATION BIOLOGY2020, VOL. 96, NO. 12, 1528–1533

Technical note: Eval…
Technical note: Evaluation of methods for reducing edge curr…

Background: Tumor-treating fields (TTFields) therapy is increasingly utilized clinically because of its demonstrated efficacy in cancer treatment. However, the risk of skin burns must still be reduced to improve patient safety and posttreatment quality of life.

Purpose: The purpose of this study was to evaluate the methods of constructing electrode arrays that reduce current density exceeding threshold values, which can cause skin burns during TTFields therapy.

Methods: Electrode and body models were generated using COMSOL software. The body model had the dielectric properties of the scalp. The average current density beneath the central region of the electrode was maintained at 31 mA/cm2 RMS. The deviations in current density at the edges of the electrode were reduced by three methods:adjustment of the ceramic thickness ratio of the center to the edge from 1/5 to 4/5, adjustment of the radius of the metal plate from 5.0 to 8.0 mm, and insertion of an insulator of width 0.5 to 2 mm at the edge.

Results: While using a single circular electrode, adjustment of the ceramic thickness ratio, adjustment of the metal plate radius, and insertion of an insulator near the edge reduced the deviations of current density by 14.6%, 67.7%, and 75.3%, respectively. Similarly, while using circular electrode arrays, inserting an insulator at the edge of each electrode reduced the deviations of current density significantly, from 8.62 to 2.40 mA/cm2.

Conclusions: Insertion of an insulator at the edge of each electrode was found to be the most effective method of attaining uniform current density distribution beneath the electrode, thereby lowering the risk of adverse effects of TTFields therapy.


Heehun Sung Geon Oh, Yongha Gi, Jaehyeon Seo

Department of Bioengineering, Korea University, Seoul,Republic of Korea

Yunhui Jo 

Institute of Global Health Technology (IGHT), Korea University, Seoul,Republic of Korea

Hyunwoo KimSangmin Park, Myonggeun Yoon

Department of Bioengineering, Korea University, Seoul,Republic of Korea

FieldCure Ltd, Seoul,Republic of Korea


Med Phys. 2022;49:4837–4844.

Feasibility of a qua…
Feasibility of a quality assurance system for electromagneti…
This study was designed to evaluate the effectiveness of a newly developed quality assurance system for electromagnetic field therapy called tumor treating fields therapy, which uses an alternating electric field to treat cancer based on an intermediate frequency of 100–300 kHz. The quality assurance system for electromagnetic field therapy consisted of a water phantom, a probe, and a digital data acquisition (DAQ) board. Low intensity alternating electric fields (200 kHz, 0–.1 V/cm) were created within the water phantom using a function generator and a high voltage amplifier. The electric potential formed inside the water phantom was measured using the probe and DAQ board. The electric field intensity was derived by measuring the electric potential at the 190 points (19×10 cm2) of the midplane. Accuracy was evaluated by gamma index analysis, which compared the measured electric field and the simulation result. The mean difference between the simulation result and the measured electric potentials within the water phantom was 0.31 V. The gamma passing rate for the tolerance levels of 0.5 V/5 mm was 95.5% for electric potential comparison showing good agreement between simulation and experimental results. The mean difference between the electric field distribution within the water phantom and the simulated values was 0.09 V/cm and the gamma passing rate for the tolerance levels of (0.2 V/cm)/5 mm was ~ 97.3%. These results confirmed the feasibility of the quality assurance system for electromagnetic field therapy.

Heehun Sung, Jaehyeon Seo, Geon Oh, Yongha Gi, Hyunwoo Kim & Myonggeun Yoon

Department of Bioengineering, Korea University, Seoul, Republic of Korea

Jong Hyun Kim & Myonggeun Yoon

FieldCure Ltd, Seoul, Republic of Korea

Yunhui Jo

Institute of Global Health Technology, Korea University, Seoul, Republic of Korea


J. Korean Phys. Soc. 81, 1029–1038 (2022). 

Development of a dos…
Development of a dosimetry system for therapeutic X-rays usi…
Purpose: To evaluate the dosimetric characteristics and applications of a dosimetry system composed of a flexible amorphous silicon thin-film solar cell and scintillator screen (STFSC-SS) for therapeutic X-rays. 
Methods: The real-time dosimetry system was composed of a flexible a Si thin-film solar cell (0.2-mm thick), a scintillator screen to increase its efficiency, and an electrometer to measure the generated charge. The dosimetric characteristics of the developed system were evaluated including its energy dependence, dose linearity, and angular dependence. Calibration factors for the signal measured by the system and absorbed dose-to-water were obtained by setting reference conditions. The application and correction accuracy of the developed system were evaluated by comparing the absorbed dose-to water measured using a patient treatment beam with that measured using the ion chamber. 
Results: The responses of STFSC-SS to energy, field size, depth, and sourceto-surface distance (SSD) were more dependent on measurement conditions than were the responses of the ion chamber, although the former dependence was due to the scintillator screen, not the solar cell. The signals of STFSC-SS were also dependent on dose rate, while the responses of solar cell alone and scintillator screen were not dependent on dose rate. The scintillator screen reduced the output of solar cell at 6 and 15 MV by 0.60 and 0.55%, respectively. The different absorbed dose-to-water measured using STFSC-SS for patient treatment beam differed by 0.4% compared to those measured using the ionization chamber. The uncertainties of the developed system for 6 and 15 MV photon beams were 1.8 and 1.7%, respectively, confirming the accuracy and applicability of this system. 
Conclusions: The thin-film solar cell-based detector developed in this study can accurately measure absorbed dose-to-water. The increased signal resulting from the use of the scintillator screen is advantageous for measuring low doses and stable signal output. In addition, this system is flexible, making it applicable to curved surfaces, such as a patient’s body, and is cost-effective.

Seonghoon Jeong, Wonjoong Cheon, Dongho Shin, Young Kyung Lim, Jonghwi Jeong, Haksoo Kim, Se Byeong Lee 
Proton Therapy Center, National Cancer Center, Goyang, Korea
Myonggeun Yoon
Department of Bioconvergence Engineering, Korea University, Seoul, Korea

Med Phys. 2022;49:4768–4779
Feasibility of a met…
Feasibility of a method for optimizing the electrode array s…
The present study investigated electrode array structures that maximize the therapeutic electric field intensity to tumors with different shapes and locations, while minimizing electric field intensity to the surrounding organs at risk (OARs). A human body phantom model was created from magnetic resonance images of a patient and divided into regions including a tumor and OARs. The shapes and sizes of the electrode arrays were altered for tumors differing in shape and location, and these electrode array structures were tested in the phantom. Use of a conformal electrode array based on the shape of the tumor maintained therapeutic electric field intensity to the tumor while reducing electric field intensity to the surrounding OARs by approximately 18%. Although the electric field intensity delivered to the tumor was proportional to the size of the electrode array, it was saturated at a critical area. Simulation results showed that optimal sizes of electrode arrays for specific tumors located at depths of 2 cm, 4 cm and 6 cm were 91, 273 and 830 cm2, respectively, indicating that the optimal size of the electrode array is proportional to the depth of tumor in the phantom. These results suggest that a tumor location-dependent optimal ratio between the size of the electrode array and the size of the individual electrodes could be calculated. In summary, this study indicated that customizing the electrode array structure to individual tumors can markedly increase the electric field intensity delivered to the tumor while minimizing the intensity delivered to OARs.

Geon Oh, Yongha Gi, Heehun Sung, Hyunwoo Kim, Jaehyeon Seo & Myonggeun Yoon

Department of Bioengineering, Korea University, Seoul, 02841, Republic of Korea

Myonggeun Yoon

FieldCure Ltd, Seoul, 02481, Republic of Korea

Yunhui Jo

Institute of Global Health Technology, Korea University, Seoul, 02841, Republic of Korea


J. Korean Phys. Soc. 81, 1020–1028 (2022).

Potential prognostic…
Potential prognostic factor in alternating electric fields t…
The present study aimed to determine a method for estimating a potential prognostic factor in alternating electric fields for the treatment of solid tumors based on cell survival curves that evaluate cell proliferation capability. In AGS, B16F10, U373, and HPAF-II cancer cell lines, the proportional relationships of the electric field magnitude and the duration of application with the proliferation of cancer cell lines was identified by in vitro alternating current electric field experiments performed under various conditions. A prognostic factor applicable to alternating electric field therapy was developed by identifying proportional relationships of the electric field magnitude and the duration of application with the proliferation of the four cancer cell lines. Through the experimental results, the absorbed energy in tissue has been suggested as a potential prognostic factor in alternating electric field therapy. The absorbed energy in tissue can be used as a reference to quantify the inhibition of cell proliferation related to control, enabling systematic assessment of alternating electric field therapy which, to date, has not been possible.

Geon Oh, Yongha Gi, Heehun Sung, Jaehyun Seo, Hyunwoo Kim

Department of Bioengineering, Korea University, Seoul 02841,Republic of Korea 

Yunhui Jo

Institute of Global Health Technology(IGHT), Korea University, Seoul 02841, Republic of Korea 

Jaemin Lee

Department of Internal Medicine, Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea 

Myonggeun Yoon

Department of Bioengineering, Korea University, Seoul 02841,Republic of Korea 

FieldCure Ltd.,Seoul 02852, Republic of Korea



AIPAdvances12,095311(2022)
Gold nanoparticles a…
Gold nanoparticles as a potent radiosensitizer in neutron th…

 The purpose of this study was to investigate the potential of gold nanoparticles as radiosensitizer for use in neutron therapy against hepatocellular carcinoma. The hepatocellular carcinoma cells lines Huh7 and HepG2 were irradiated with γ and neutron radiation in the presence or absence of gold nanoparticles. Effects were evaluated by transmission electron microscopy, cell survival, cell cycle, DNA damage, migration, and invasiveness. Gold nanoparticles significantly enhanced the radiosensitivity of Huh7 and HepG2 cells to γ-rays by 1.41- and 1.16-fold, respectively, and by 1.80- and 1.35-fold to neutron radiation, which has high linear energy transfer. Accordingly, exposure to neutron radiation in the presence of gold nanoparticles induced cell cycle arrest, DNA damage, and cell death to a significantly higher extent, and suppressed cell migration and invasiveness more robustly. These effects are presumably due to the ability of gold nanoparticles to amplify the effective dose from neutron radiation more efficiently. The data suggest that gold nanoparticles may be clinically useful in combination therapy against hepatocellular carcinoma by enhancing the toxicity of radiation with high linear energy transfer.


Eun Ho Kim1, Mi-Sook Kim2, Hyo Sook Song3, Seung Hoon Yoo1, Sei Sai4, Kwangzoo
Chung5, Jiwon Sung3, Youn Kyoung Jeong6, YunHui Jo3 and Myonggeun Yoon3
1.Division of Heavy Ion Clinical Research, Korea Institute of Radiological and Medical Sciences, Seoul, Korea
2.Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences, Seoul, Korea
3.Department of Bio-convergence Engineering, Korea University, Seoul, Korea
4.Department of Basic Medical Sciences for Radiation Damages, National Institute of Radiological Sciences, Chiba, Japan
5.Department of Radiation Oncology, Samsung Medical Center, Seoul, Korea
6.Research Center for Radiotherapy, Korea Institute of Radiological and Medical Sciences, Seoul, Korea

Oncotarget, 2017, Vol. 8, (No. 68)
Study on the Dose Un…
Study on the Dose Uncertainties in the Lung during Passive P…
A moving phantom is manufactured for mimicking lung model to study the dose uncertainty from CT number-stopping power conversion and dose calculation in the soft tissue, light lung tissue and bone regions during passive proton irradiation with compensator smearing value. The phantom is scanned with a CT system, and a proton beam irradiation plan is carried out with the use of a treatment planning system (Eclipse). In the case of the moving phantom, a RPM system is used for respiratory gating. The uncertainties in the dose distribution between the measured data and the planned data are investigated by a gamma analysis with 3%-3 mm acceptance criteria. To investigate smearing effect, three smearing values (0.3 cm, 0.7 cm, 1.2 cm) are used to for fixed and moving phantom system. For both fixed and moving phantom, uncertainties in the light lung tissue are severe than those in soft tissue region in which the dose uncertainties are within clinically tolerable ranges. As the smearing value increases, the uncertainty in the proton dose distribution decreases.

Seung Hoon Yoo
Division of Heavy-Ion Clinical Research, Korea Institute of Radiological and Medical Science, Seoul 01812, Korea
Jae Man Son and Myonggeun Yoon
Department of Department of Bio-Convergence Engineering, Korea University, Seoul 02841, Korea
Sung Yong Park
McLaren Proton Therapy Center, McLaren Cancer Institute, Flint, Michigan 48532, USA
Dongho Shin
Proton Therapy Center, National Cancer Center, Goyang 10408, Korea
Byung Jun Min
Department of Radiation Oncology, Kangbuk Samsung Hospital,
Sungkyunkwan University School of Medicine, Seoul 03181, Korea

Journal of the Korean Physical Society, Vol. 72, No. 11, June 2018, pp. 1369∼1378
Effectiveness of a F…
Effectiveness of a Fractionated Therapy Scheme in Tumor Trea…
  This study aimed to evaluate the biological effectiveness of cancer therapy with tumor treating fields using a fractionated
treatment scheme that was originally designed for radiotherapy. Discontinuous fractional tumor treating fields of an intensity of
0.9 to 1.2 V/cm and a frequency of 150 KHz were applied to U373 cancer cells and IEC6 normal cells for 3 days, with durations of 3, 6, 12, or 24 h/d. As the treatment duration of the tumor treating fields increased from 3 to 24 h/d, the relative tumor cell (U373) number (% of control) reduced in proportion to the treatment duration. Compared to a 25% cell number reduction (75% of
control) for the group of 6 h/d treatment at 1.2 V/cm, only 5% (70% of control) and 8% (67% of control) of additional reductions
were observed for the group of 12 and 24 h/d treatment, respectively. This experimental result indicates that the dependence on
treatment duration in tumor cell inhibition was weakened distinctly at treatment duration over 6 h/d. For normal cells (IEC6), the
relative cell number corresponding to the treatment time of the tumor treating fields at 1.2 V/cm of electric field strength was not
decreased much for the treatment times of 3, 6, and 12 h/d, revealing 93.3%, 90.0%, and 89.3% relative cell numbers, respectively, but it suddenly decreased to *73% for the 24 h/d treatment. Our results showed that the effects of tumor treating fields on tumor cells were higher than on normal cells for treatment duration of 3 to 12 h/d, but the difference became minimal for treatment duration of 24 h/d. The fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy, suggesting that this method may be clinically applicable for cancer treatment.

Yunhui Jo, BS1,2, Jiwon Sung, PhD1, Hyesun Jeong, MS3,
Sunghoi Hong, PhD3, Youn Kyoung Jeong, PhD4, Eun Ho Kim, PhD2, and
Myonggeun Yoon, PhD1

Technology in Cancer Research & Treatment
Volume 18: 1-10 The Author(s) 2019

Quantitative study o…
Quantitative study of fast non-local means-based denoising f…
In chest radiography, a solitary pulmonary nodule, which may be a precursor of lung cancer, is a frequently detected finding. However, as the image quality is deteriorated owing to the increase in the noise, lung cancer screening studies revealed that the likelihood of finding a nodule is lower than those of other modalities. This study quantitatively evaluates three widely used filters (median, Wiener, and total variation) and a newly proposed filter (fast non-local means (FNLM)), which reduce image noise. Images of a phantom with lung nodules, obtained from a patient using the 3D printing technology, were acquired at the chest anterior–posterior, lateral, and posterior– anterior positions. To evaluate their denoising performance, normalized noise power spectrum, contrast to noise ratio and coefficient of variation were used. In the quantitative evaluation
of the overall image, the proposed FNLM filter exhibited the best image performance. In the quantitative evaluation of the nodule image, the FNLM filter, which exhibits outstanding denoising performance and time efficiency, can be employed. Therefore, with the use of the FNLM filter in chest radiography, the detection probability of a nodule, which can be a precursor of lung
cancer, is increased, and the cancer can be prevented even with a lower dose. 


Jina Shim, Myonggeun Yoon, Youngjin Lee
a Department of Bio-Convergence Engineering, Korea University, 145, Anam-ro, Seongbuk-gu, Seoul, Republic of Korea
b Department of Diagnostic Radiology, Severance Hospital, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea
c Department of Radiological Science, Gachon University, 191, Hambakmoero, Yeonsu-gu, Incheon, Republic of Korea

Optik - International Journal for Light and Electron Optics 179(2019)
Toward a novel dosim…
Toward a novel dosimetry system using acrylic disk radiation…
Purpose: Fabricate an acrylic disk radiation sensor (ADRS) and characterize the photoluminescence
signal generated from the optical device as basis for the development and evaluation of a new
dosimetry system for pencil beam proton therapy.
Methods: Based on the characteristics of the proposed optical dosimetry sensor, we established the
relation between the photoluminescence output and the applied dose using an ionization chamber.
Then, we obtained the relative integral depth dose profiles using the photoluminescence signal generated
by pencil beam irradiation at energies of 99.9 and 162.1 MeV, and compared the results with the
curve measured using a Bragg peak ionization chamber.
Results: The relation between the photoluminescence output and applied dose was linear. In addition,
the ADRS was dose independent for beam currents up to 6 Gy/min, and the calibration factor
for energy was close to 1. Hence, the energy dependence on the optical device can be disregarded.
The integral depth dose profiles obtained for the ADRS suitable agreed with the curve measured in
the Bragg peak ionization chamber without requiring correction.
Conclusions: These results suggest that the ADRS is suitable for dosimetry measurements in pencil
beam scanning, and it will be employed as a low-cost and versatile dosimetry sensor in upcoming
developments. 

Shinhaeng Cho
Proton Therapy Center, National Cancer Center, Goyang, Korea
Nuri Lee
Department of Radiation and Oncology, National Medical Center, Seoul, South Korea
Sanghyeon Song
Department of Radiation and Oncology, Soon Chun Hyang University Hospital, Seoul, South Korea
Jaeman Son
Department of Radiation and Oncology, Seoul National University Hospital, Seoul, South Korea
Haksoo Kim, Jong Hwi Jeong, Se Byeong Lee, and Youngkyung Lim
Proton Therapy Center, National Cancer Center, Goyang, Korea
Sunyoung Moon and Myonggeun Yoon
Department of Bio-Convergence Engineering, Korea University, Seoul, Korea
Dongho Shina)
Proton Therapy Center, National Cancer Center, Goyang, Korea

Med. Phys. 45(11), November 2018

Development of Beam …
Development of Beam Monitoring System for Proton Pencil Beam…
 We aimed to develop a beam monitoring system based on a fiber-optic radiation sensor (FORS),
which can be used in real time in a beam control room, to monitor a beam in proton therapy, where
patients are treated using a pencil beam scanning (PBS) mode, by measuring the beam spot width
(BSW) and beam spot position (BSP) of the PBS. We developed two-dimensional detector arrays to
monitor the PBS beam in the beam control room. We measured the BSW for five energies of the PBS
beam and compared the measurements with those of Lynx and EBT3 film. In order to confirm the
BSP, we compared the BSP values of the PBS calculated from radiation treatment planning (RTP),
to five BSP values measured using FORS at 224.2 MeV. When comparing BSW values obtained
using developed monitoring system to the measurements obtained using commercial EBT3 film, the
average difference in BSW value of the PBS beam was 0.1 ± 0.1 mm. In the comparison of BSW
values with the measurements obtained using Lynx, the average difference was 0.2 ± 0.1 mm. When
comparing BSP measurements to the values calculated from RTP, the average difference was 0.4 ±
0.2 mm. The study results confirmed that the developed FORS-based beam monitoring system can
monitor a PBS beam in real time in a beam control room, where proton beam is controlled for the
patient.

Jaeman Son,∗ Jihye Koo, Sunyoung Moon and Myonggeun Yoon
Department of Bio-convergence Engineering, Korea University, Seoul 10408, Korea
Jonghwi Jeong,∗ Sun-Young Kim, Youngkyung Lim, Se Byeong Lee and Dongho Shin
Proton Therapy Center, National Cancer Center, Goyang 02841, Korea
Meyoung Kim
Research Center, Dongnam Institute of Radiological & Medical Sciences (DIRAMS), Busan 46033, Korea
Dongwook Kim
Department of Radiation Oncology, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea

Journal of the Korean Physical Society, Vol. 71, No. 7, October 2017, pp. 438∼443
 1  2  3  4